Reduction assessment of cold or flu symptoms with Fluviral® compared to Resfenol®, in adult participants
- Conditions
- Flu, Commom Cold.C02.782.687.207C02.782.620.375
- Registration Number
- RBR-3p4npx
- Lead Sponsor
- Hospital das Clínicas de Porto Alegre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Adults; Both genders; Age between 18 and 60; Patients diagnosed with flu or cold with congestive and exudative symptoms such as corizas, muscle aches, fever, headache, nasal congestion and other symptoms present in Influenza like illness; Women of childbearing potential should be sexually inactive or be using one of the acceptable methods of contraception; Women without childbearing potential must be surgically sterile or already have over 2 years post-menopause.
History of hypersensitivity to the components of the study formulations; history of alcohol or drug abuse; bronchial asthma, severe kidney or liver disease, high blood pressure, heart disease, diabetes, thyroid dysfunction, glaucoma or prostatic hypertrophy; history of asthma maintenance therapy and/or asthma attacks in the last 5 years; clinical evidence of immunosuppression; use of monoamine oxidase inhibitor medicines (eg .: phenelzine, iproniazid, isocarboxazid, harmaline, nialamide, pargyline, selegiline, toloxatone, tranylcypromine, moclobemide); surgery or dental intervention with general or spinal anesthesia; be vaccinated against the flu less than 1 week prior to study enrollment; use of tricyclic antidepressants (amitriptyline, clomipramine, imipramine), barbiturates or oral anticoagulants; pregnant or nursing women.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method